I get a real sense that momentum with BTM is really building strongly in the UK/Europe (esp DACH region). The fact that this is a paediatric conference bodes well. I would say in general surgeons would normally try new products like BTM on adults first or wait and see results in adults before using in a paed setting, but with recent BBA conference and now this reporting multiple paed cases I think the reins are about to come off and sales are going to gallop away. Fair chance DW might have seen some UK/Europe sales figures!!!
The Clinicians Speak, page-149
-
- There are more pages in this discussion • 873 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PNV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.30 |
Change
0.000(0.00%) |
Mkt cap ! $1.587B | |||
| Open | High | Low | Value | Volume |
| $2.34 | $2.35 | $2.27 | $1.711M | 744.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 14000 | $2.28 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.30 | 13896 | 5 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| PNV (ASX) Chart |